|
|
| | 5-Chloro Dasatinib Basic information |
| Product Name: | 5-Chloro Dasatinib | | Synonyms: | 5-Chloro Dasatinib;N-(3,6-dichloro-2-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | | CAS: | 2468737-75-7 | | MF: | C22H25Cl2N7O2S | | MW: | 522.45 | | EINECS: | | | Product Categories: | | | Mol File: | 2468737-75-7.mol |  |
| | 5-Chloro Dasatinib Chemical Properties |
| Melting point | >196°C (dec.) | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Slightly, Heated) | | form | Solid | | color | White to Off-White |
| | 5-Chloro Dasatinib Usage And Synthesis |
| Uses | 5-Chloro-dasatinib, is an impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product. |
| | 5-Chloro Dasatinib Preparation Products And Raw materials |
|